1. AstraZeneca falls as cancer drug disappoints, analysts cut FDA approval chances
Late-stage trial results of the TROPION-Lung01 showed that the overall survival rate from the new drug “did not reach statistical significance”.
2. FTSE 100 slips again
London's blue chips returned to negative territory on Tuesday, led lower by AstraZeneca.
3. Apple iPhone 16 debut leaves much to be desired with AI upgrades
Apple shares fell on Tuesday as the technology giant's iPhone 16 launch underwhelmed.
4. Asda market share slips as Ocado outpaces brick-and-mortar rivals
Asda retained its status as the UK's third-largest supermarket, but the gulf between its and rivals' volumes continued to widen.
5. UK jobs data sends mixed signals to Bank of England
Employment in the UK increased by 265,000 in July, marking the largest rise in over 18 months and clobbering forecasts.
And with small caps
hVIVO sets £100 million revenue target as it reaffirms 2024 guidance